COMMUNIQUÉS West-GlobeNewswire

Precision Optics Corporation, Inc. Announces Operating Results for the First Quarter of Fiscal Year 2018 Ended September 30, 2017
14/11/2017
GARDNER, Mass., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the “Company”) today announced operating results on an unaudited basis for its first quarter ended September 30, 2017. [...]
Profound Medical Corp. to Present at the 29th Annual Piper Jaffray Healthcare Conference
14/11/2017
TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular Risk
14/11/2017
BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Veritas Pharma Initiates Cancer Research with Dr. Dmitri Petchkovski
14/11/2017
VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT); (OTC:VRTHF); and (Frankfurt: 2VP ), (“Veritas” or the “Company”) announces that it has initiated a cancer research project to [...]
The Cooper Companies to Present at BMO Healthcare Conference
14/11/2017
PLEASANTON, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) will present at the BMO Prescriptions for Success Healthcare Conference in New York, NY, on December 14, 2017. Daniel G. [...]
Molecular Templates Strengthens Management Team with Appointment of Adam Cutler as Chief Financial Officer
14/11/2017
Company Also Added Key Members to the Senior Management Team Barbara Ruskin J.D. Ph.D. Appointed SVP, General Counsel and Chief Patent Officer Nenad Sarapa M.D. M.S. Appointed SVP of Clinical Development Conrad Jordaan [...]
Precipio Appoints Samuel D. Riccitelli as Chairman of the Board of Directors and Elects David Cohen as Director
14/11/2017
NEW HAVEN, Conn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), today announced that on November 8, 2017, Precipio’s Board of Directors (the “Board”) appointed Samuel D. Riccitelli as Chairman, [...]
Asterias Biotherapeutics Reports Third Quarter Financial Results and Recent Developments
14/11/2017
- Continues to execute on key clinical programs and streamline cost structure - - Conference call and webcast today, November 14, at 4:30 p.m. ET - FREMONT, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Asterias [...]
HealthEquity Sets Date to Announce Third Quarter Results
14/11/2017
DRAPER, Utah, Nov. 14, 2017 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ) (“HealthEquity” or the “Company”), the largest HSA non-bank custodian, today announced that it plans to release its third quarter of [...]
aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update
14/11/2017
- Initiation of Phase 1 clinical trial of iMod.Fc on-track for this quarter - - Selection of antibody for ORCA program on-track for this quarter - SAN DIEGO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: [...]
Evoke Pharma Reports Third Quarter 2017 Results and Highlights
14/11/2017
Announced positive topline results from comparative exposure pharmacokinetic (PK) trial for Gimoti™ 505(b)(2) New Drug Application (NDA) submission on track for Q1 2018 filing Partnered with the Patheon division of [...]
Entellus Medical to Participate in Upcoming Investor Conferences
14/11/2017
PLYMOUTH, Minn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ: ENTL ), a medical technology company focused on delivering minimally invasive ENT procedures, today announced the Company plans to [...]
Fluidigm to Participate in the 29th Annual Piper Jaffray Healthcare Conference
14/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in [...]
Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update
14/11/2017
RANCHO CORDOVA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced [...]
Achillion Announces Proposed Secondary Offering of Common Stock
14/11/2017
NEW HAVEN, Conn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (“Achillion”) (NASDAQ: ACHN ) today announced that Johnson & Johnson Innovation-JJDC, Inc. (“JJDC”), an existing stockholder of [...]
Aptevo Therapeutics to Present at the 29th Annual Piper Jaffray Healthcare Conference
14/11/2017
SEATTLE, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that management will be [...]
Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results
14/11/2017
Completed Merger with Threshold Pharmaceuticals in August Recent Equity Financings of $60 Million Provide Cash Runway into late 2019 MT-3724 Advancing in Clinical Trials with New Data Expected in 1H18 AUSTIN, Texas, Nov [...]
Invuity to Present at Upcoming Investor Conferences
14/11/2017
SAN FRANCISCO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to attend the [...]
Achillion Reports Preliminary Proof-of-Concept With ACH-4471 for the Treatment of C3G
14/11/2017
- Greater than 50% improvement in proteinuria (albumin to creatinine ratio) after 14 days of oral dosing with ACH-4471 - - Improvement in complement alternative pathway biomarkers observed - NEW HAVEN, Conn., Nov. 14, [...]

Pages